This page shows the latest Aileron Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Bergstorm joins the biotech from Mersana Therapeutics, where he led the advancement of two oncology products. ... Catinazzo brings over 12 years’ experience in the biotech field having worked at Aileron Therapeutics and Genzyme Corporation supporting
In the 25 years since, she has spent more than a decade in vice president-level positions at Pfizer Global R&D and as chief development and medical officer at Aileron ... Therapeutics. Most recently, Dr Jorkasky was appointed senior vice president,
platforms. Aileron Therapeutics has signed a broad alliance with Roche worth a headline $1.1bn to develop new drug candidates against up to five undisclosed targets in Roche's key therapeutic ... Lorcaserin - obesity/weight management (US). NDA . 1, 370.
Roche has entered into an agreement with Aileron Therapeutics for the development of stapled peptides, a new type of drug delivery technology. ... Roche has entered into an agreement with Aileron Therapeutics to develop and commercialise stapled peptides,
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
He has experience at EMD Serono, Pfizer and AstraZeneca. Aileron Therapeutics has added to its senior team with the appointment of Evan Lippman as its first chief financial and business officer. ... In Lippman Aileron gains the expertise of a man with
His replacement Dr Verdine helped launch the company in 2012 after an entrepreneurial career that included co-founding several biotech companies, including Enanta Pharmaceuticals, Gloucester Pharmaceuticals, Aileron Therapeutics, Tokai
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...